eukaryotic
@eukaryotic
San Diego startup Gallant just scored $18M to launch the first FDA-approved stem cell therapy for pets. If approved, it could revolutionize how we treat our furry friends. Stem cell research isn’t new, but this ready-to-use treatment is still experimental. A potential game-changer for vet medicine.
0 reply
0 recast
0 reaction